Filters

516 Results

relevance


23andMe

Ad Alert

23andMe

Company seeking to provide genetic information grapples with FDA.

Crystal Flush

Ad Alert

Crystal Flush

A number of deceptive marketing issues should keep consumers on their toes.

Ocanna CBD

Ad Alert

Ocanna CBD

Disease-treatment claims vanish in wake of FTC warning letter.

RiduZone

Ad Alert

RiduZone

Weight-loss supplement is sending mixed signals with its use of the FDA logo in a claim on its website that it is ‘FDA Acknowledged.’

Juul

Ad Alert

Juul

FDA zeros in on e-cigarette company’s marketing of flavors and their appeal to youth in an effort to curb underage use.

The McShane Letter

Ad Alert

The McShane Letter

We received something called the McShane Letter via snail mail. Something about it seems off: There’s a lot going on here. Even in the first sentence: Donald B. McShane is…

U.S. Stem Cell Clinic

Ad Alert

U.S. Stem Cell Clinic

Florida facility becomes one of the FDA’s initial targets in a crackdown on stem cell clinics across the country.

NuLife CBD

Ad Alert

NuLife CBD

Disease-treatment claims vanish in wake of FTC warning letter.

Prevagen

Ad Alert

Prevagen

Brain supplement faces lawsuit over improved brain function claims.

Natural Alchemist

Ad Alert

Natural Alchemist

FDA reminds marijuana marketers that outing unproven treatment claims remains high on its list.

Green Roads Health

Ad Alert

Green Roads Health

FDA reminds marijuana marketers that outing unproven treatment claims remains high on its list.

Show More